ALPS Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,431
Closed -$440K 1041
2025
Q4
$440K Buy
16,431
+181
+1% +$4.66K ﹤0.01% 828
2025
Q3
$433K Buy
+16,250
New +$420K ﹤0.01% 863
2025
Q1
Sell
-7,395
Closed -$275K 1001
2024
Q4
$275K Hold
7,395
﹤0.01% 941
2024
Q3
$359K Sell
7,395
-494
-6% -$21.7K ﹤0.01% 826
2024
Q2
$316K Sell
7,889
-39
-0.5% -$1.62K ﹤0.01% 822
2024
Q1
$348K Buy
7,928
+1,717
+28% +$88.7K ﹤0.01% 842
2023
Q4
$384K Sell
6,211
-355
-5% -$18.6K ﹤0.01% 704
2023
Q3
$302K Sell
6,566
-2,325
-26% -$127K ﹤0.01% 880
2023
Q2
$511K Buy
8,891
+65
+0.7% +$2.88K ﹤0.01% 611
2023
Q1
$331K Sell
8,826
-2,075
-19% -$68K ﹤0.01% 749
2022
Q4
$305K Sell
10,901
-53
-0.5% -$1.54K ﹤0.01% 872
2022
Q3
$308K Buy
+10,954
New +$358K ﹤0.01% 736
2017
Q3
Sell
-39,250
Closed -$701K 780
2017
Q2
$701K Buy
39,250
+101
+0.3% +$1.6K ﹤0.01% 293
2017
Q1
$568K Buy
39,149
+15,820
+68% +$249K ﹤0.01% 307
2016
Q4
$430K Buy
23,329
+221
+1% +$4.3K ﹤0.01% 535
2016
Q3
$438K Buy
+23,108
New +$419K ﹤0.01% 370

Other funds holding AMPH